Ascendis Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ASND and other ETFs, options, and stocks.

About ASND

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. 

CEO
Jan Møller Mikkelsen
CEOJan Møller Mikkelsen
Employees
—
Employees—
Headquarters
Hellerup, Capital Region
HeadquartersHellerup, Capital Region
Founded
2006
Founded2006
Employees
—
Employees—

ASND Key Statistics

Market cap
13.24B
Market cap13.24B
Price-Earnings ratio
-51.01
Price-Earnings ratio-51.01
Dividend yield
—
Dividend yield—
Average volume
742.60K
Average volume742.60K
High today
$216.96
High today$216.96
Low today
$209.79
Low today$209.79
Open price
$213.90
Open price$213.90
Volume
652.19K
Volume652.19K
52 Week high
$229.94
52 Week high$229.94
52 Week low
$118.03
52 Week low$118.03

ASND News

TipRanks 2d
Ascendis Pharma price target raised to $250 from $245 at RBC Capital

RBC Capital raised the firm’s price target on Ascendis Pharma (ASND) to $250 from $245 and keeps an Outperform rating on the shares after meeting with its manag...

Analyst ratings

94%

of 17 ratings
Buy
94.1%
Hold
0%
Sell
5.9%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.